(Q47220919)

12 January 2018

review article

1 reference

title

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria (English)

1 reference

12 January 2018

0 references

1

1 reference

12 January 2018

Mar Tintoré

Mar Tintoré

22

0 references

Maria Trojano

Maria Trojano

24

0 references

Massimo Filippi

Massimo Filippi

9

0 references

Per Soelberg Sørensen

Per Soelberg Sorensen

21

0 references

Ellen M Mowry

Ellen M Mowry

20

0 references

Ludwig Kappos

14

Ludwig Kappos

1 reference

12 January 2018

3

Frederik Barkhof

1 reference

12 January 2018

6

Giancarlo Comi

1 reference

12 January 2018

12

Steven L Galetta

1 reference

12 January 2018

8

Franz Fazekas

1 reference

12 January 2018

27

Emmanuelle Waubant

1 reference

12 January 2018

18

David H Miller

1 reference

12 January 2018

Brian G Weinshenker

28

Brian G Weinshenker

1 reference

12 January 2018

Hans-Peter Hartung

13

Hans Peter Hartung

1 reference

12 January 2018

Xavier Montalban

19

Xavier Montalban

1 reference

12 January 2018

Brenda L Banwell

2

Brenda L Banwell

1 reference

12 January 2018

Mark S Freedman

10

Mark S Freedman

1 reference

12 January 2018

Bernard Uitdehaag

25

Bernard M J Uitdehaag

1 reference

12 January 2018

Anthony Traboulsee

23

Anthony L Traboulsee

1 reference

12 January 2018

Sandra Vukusic

26

Sandra Vukusic

1 reference

12 January 2018

Stephen C. Reingold

29

Stephen C Reingold

1 reference

12 January 2018

Kazuo Fujihara

11

Kazuo Fujihara

1 reference

12 January 2018

Fred D. Lublin

15

Fred D Lublin

1 reference

12 January 2018

author name string

William M Carroll

4

1 reference

12 January 2018

Timothy Coetzee

5

1 reference

12 January 2018

Jorge Correale

7

1 reference

12 January 2018

Ruth Ann Marrie

16

1 reference

12 January 2018

Aaron E Miller

17

1 reference

12 January 2018

Jeffrey A Cohen

30

1 reference

12 January 2018

publication date

21 December 2017

1 reference

12 January 2018

published in

Lancet Neurology

1 reference

12 January 2018

PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Diagnosis of multiple sclerosis: progress and challenges

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Differential diagnosis of suspected multiple sclerosis: a consensus approach

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Defining the clinical course of multiple sclerosis: the 2013 revisions

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Intracortical lesions: relevance for new MRI diagnostic criteria for multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Diagnosis of multiple sclerosis: a multicentre study to compare revised McDonald-2010 and Filippi-2010 criteria

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

MRI mimics of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—clinical implementation in the diagnostic process

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Misdiagnosis of multiple sclerosis and beta-interferon

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Initial evaluations for multiple sclerosis in a university multiple sclerosis center: outcomes and role of magnetic resonance imaging in referral

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

The contemporary spectrum of multiple sclerosis misdiagnosis: A multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

The tension between early diagnosis and misdiagnosis of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Multiple sclerosis. The problem of incorrect diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

MRI and the diagnosis of multiple sclerosis: expanding the concept of "no better explanation".

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Application and a proposed modification of the 2010 McDonald criteria for the diagnosis of multiple sclerosis in a Canadian cohort of patients with clinically isolated syndromes.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Risk of multiple sclerosis following clinically isolated syndrome: a 4-year prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Application of the 2010 revised criteria for the diagnosis of multiple sclerosis to patients with clinically isolated syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Application of the 2010 McDonald criteria for the diagnosis of multiple sclerosis in a Spanish cohort of patients with clinically isolated syndromes.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Revised McDonald criteria for multiple sclerosis diagnostics in central Russia: sensitivity and specificity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Comparison of the 2010 and 2005 versions of the McDonald MRI criteria for dissemination-in-time in Taiwanese patients with classic multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Evaluation of McDonald MRI criteria for dissemination in space in Korean patients with clinically isolated syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Multiple sclerosis in Japan appears to be a milder disease compared to the UK.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Predictors of Conversion to Multiple Sclerosis in Patients with Clinical Isolated Syndrome Using the 2010 Revised McDonald Criteria

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Consensus guidelines for the diagnosis and treatment of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Application of the McDonald 2010 criteria for the diagnosis of multiple sclerosis in an Argentinean cohort of patients with clinically isolated syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Central nervous system infectious diseases mimicking multiple sclerosis: recognizing distinguishable features using MRI.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Evaluation of the 2010 McDonald multiple sclerosis criteria in children with a clinically isolated syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

2010 McDonald criteria for diagnosing pediatric multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Paediatric multiple sclerosis: examining utility of the McDonald 2010 criteria.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

2010 McDonald criteria in a pediatric cohort: is positivity at onset associated with a more aggressive multiple sclerosis course?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Predicting multiple sclerosis following isolated optic neuritis in children

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Pediatric onset multiple sclerosis: McDonald criteria 2010 and the contribution of spinal cord MRI

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Risk of multiple sclerosis after a first demyelinating syndrome in an Australian Paediatric cohort: clinical, radiological features and application of the McDonald 2010 MRI criteria

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Use of the 2010 McDonald criteria can facilitate early diagnosis of pediatric multiple sclerosis in a predominantly black cohort

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Acute disseminated encephalomyelitis: Updates on an inflammatory CNS syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Anti–Myelin Oligodendrocyte Glycoprotein Antibodies in Pediatric Patients With Optic Neuritis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Myelin oligodendrocyte glycoprotein antibodies are associated with a non-MS course in children

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Diagnostic algorithm for relapsing acquired demyelinating syndromes in children

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Clinical characteristics of patients with late-onset multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Diagnosing multiple sclerosis at a later age: more than just progressive myelopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Treatment of neuromyelitis optica: state-of-the-art and emerging therapies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Myelin injury without astrocytopathy in neuroinflammatory disorders with MOG antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

MOG cell-based assay detects non-MS patients with inflammatory neurologic disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

International consensus diagnostic criteria for neuromyelitis optica spectrum disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Treatment of Neuromyelitis Optica: Review and Recommendations.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis--establishing disease prognosis and monitoring patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Revised Recommendations of the Consortium of MS Centers Task Force for a Standardized MRI Protocol and Clinical Guidelines for the Diagnosis and Follow-Up of Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

CSF examination still has value in the diagnosis of MS - Commentary.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

The utility of cerebrospinal fluid analysis in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Prevalence of cerebrospinal fluid oligoclonal IgG bands in Greek patients with clinically isolated syndrome and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Cerebrospinal fluid oligoclonal bands in multiple sclerosis and clinically isolated syndromes: a meta-analysis of prevalence, prognosis and effect of latitude

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Conversion from clinically isolated syndrome to multiple sclerosis: A large multicentre study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Defining high, medium and low impact prognostic factors for developing multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Importance of cerebrospinal fluid analysis in the era of McDonald 2010 criteria: a German-Austrian retrospective multicenter study in patients with a clinically isolated syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Multiple biomarkers improve the prediction of multiple sclerosis in clinically isolated syndromes.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

The value of oligoclonal bands in the multiple sclerosis diagnostic criteria.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Should the symptomatic region be included in dissemination in space in MRI criteria for MS?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Contribution of the symptomatic lesion in establishing MS diagnosis and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Grey matter pathology in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Periventricular lesions and MS diagnostic criteria in young adults with typical clinically isolated syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Lesion topographies in multiple sclerosis diagnosis: A reappraisal

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Vision and vision-related outcome measures in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Incidence of Radiologically Isolated Syndrome: A Population-Based Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Prevalence of radiologically isolated syndrome and white matter signal abnormalities in healthy relatives of patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Radiologically isolated syndrome: 5-year risk for an initial clinical event

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Asymptomatic spinal cord lesions predict disease progression in radiologically isolated syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Primary Progressive Multiple Sclerosis Evolving From Radiologically Isolated Syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Impact of pregnancy on conversion to clinically isolated syndrome in a radiologically isolated syndrome cohort

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Evaluation of quality of life and fatigue in radiologically isolated syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Cognitive function in radiologically isolated syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Early CNS neurodegeneration in radiologically isolated syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Progressive solitary sclerosis: Gradual motor impairment from a single CNS demyelinating lesion.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Diagnostic value of brain chronic black holes on T1-weighted MR images in clinically isolated syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Seven-tesla phase imaging of acute multiple sclerosis lesions: a new window into the inflammatory process

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Morphological features of MS lesions on FLAIR* at 7 T and their relation to patient characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

Will Rogers phenomenon in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930470-2

7 January 2021

10.1016/S1474-4422(17)30470-2

Identifiers

DOI

1 reference

12 January 2018

1 reference

12 January 2018